World Congress on Biosensors 2014

World Congress on Biosensors 2014
Biosensors 2014

Tuesday, 28 September 2010

2011 Herman Skolnik Award Winner Announced

Dr. Alexander (Sandy) Lawson will be the recipient of the 2011 Herman Skolnik Award presented by the ACS Division of Chemical Information (CINF). The award recognizes outstanding contributions to and achievements in the theory and practice of chemical information science and related disciplines. The prize consists of a $3,000 honorarium and a plaque. The winner will also be invited to present an award symposium at the Fall 2011 ACS Meeting.

Sandy Lawson is recognized as a pioneer and far-sighted visionary in the fields of chemical structure handling, database searching, chemical nomenclature, reading machines, and linking text and structural information. He has made numerous innovative contributions, often struggling with the limitations of nascent technology, to develop early prototypes to validate concepts, which sometimes only bore fruit when the technology caught up with his ideas. Sandy has spent a large part of his career associated with "Beilstein," initially working with the Beilstein Handbook. As early aids to searching in Beilstein, he developed the Lawson Number and the SANDRA program. He was instrumental in the creation and development of the electronic Beilstein Database, including both the organization, data structure, and indexing, and also the development of the powerful CrossFire search engine and interface, capable of handling millions of molecules, reactions, and properties.

Sandy has a deep and abiding interest in chemical nomenclature and has been active on IUPAC Committees for Publications, Databases, and Structural Representation, including Division VIII Chemical Nomenclature of Organic Structures. His expertise lead him and his team to develop the first commercial program for generating systematic names from structures, AUTONOM, and then its counterpart, to generate structures from names. More recently Sandy has been involved in the consolidation of Beilstein, Gmelin, and Patent Chemistry Database into a unified database with modern and chemist-friendly interface, Reaxys. In his current role within Reed Elsevier, and in earlier organizations, he pioneered building bridges between the structured world of molecules and reactions in databases and the looser but nonetheless related realm of text in journals, and the early DYMOND Linking project presaged later developments such as Project Prospect from the Royal Society of Chemistry.

Sandy Lawson received a B.Sc. from the University of St. Andrews, and a Ph.D. and D.I.C. from the University of London. He did post-graduate work at the Universities of Kent and Mainz, and was an extramural professor at the latter. He has been awarded the Irvine Medal (1966), Forrester Prize (1966), Gold Medal (1985, for Sandra), EuroCase IT Prizewinner (1997, for CrossFire), and the CSA Trust Mike Lynch Award (2008). He has continued to pursue his love of cheminformatics research and development through a series of organizations, including the Beilstein Institute, Beilstein Informationssysteme GmbH, MDL Information Systems GmbH, Elsevier Information Systems GmbH, and latterly Elsevier Properties SA in Neuchâtel.

Sandy Lawson is among the handful of truly excellent cheminformatics scientists at work today, and is widely and thoroughly respected. He is a gentleman's scientist with a tremendous understanding of chemistry and computers. He embodies the best qualities of cheminformatics and is truly worthy of this award.

Micronic Launches Informative Multi-media Sample Storage Website...

Micronic Europe has announced the launch of a new comprehensively featured website (http://www.micronic.com/) designed to offer a wide variety of useful information to organisations involved with safeguarding one of their most valuable assets - their samples.

JUST PUBLISHED: The latest issue of Talanta


Click on the link below for papers published in the latest issue of Talanta http://rss.sciencedirect.com/publication/science/5288

National Government Standards Lab Selects JEOL Atomic Resolution Microscope

JEOL announces a major order for the company's atomic resolution analytical JEM-ARM200F Transmission Electron Microscope (TEM), from the National Institute of Standards and Technology (NIST). The purchase was made through a competitive award process and funded by the American Recovery and Reinvestment Act. The TEM will be a featured instrument in the NIST Precision Measurement Laboratory, Boulder, Colorado.

"We are very excited to be partnering with this premier federal government facility and are confident the opportunity will recognize the high performance capability of this new TEM platform," said Peter Genovese, JEOL USA President. “We believe having hands-on access will open up unexplored horizons and world-class results for the scientific team who will be using it.”
 
The ARM200F, introduced in 2009, has set a new benchmark for advanced aberration-corrected S/TEM technology with the highest resolution (78pm) commercially available in its class.  The instrument represents more than 60 years of TEM expertise at JEOL and was designed from the ground up to integrate aberration correction into a super-shielded electron column that safeguards the ultrahigh-powered optics from environmental interferences.
 
JEOL USA, Inc.
JEOL is a world leader in electron optical equipment and instrumentation for high-end scientific and industrial research and development. Core product groups include electron microscopes (SEMs and TEMs), instruments for the semiconductor industry (electron beam lithography and a series of defect review and inspection tools), and analytical instruments including mass spectrometers, NMRs and ESRs.JEOL USA, Inc., is a wholly owned subsidiary of JEOL, Ltd., Japan, was incorporated in the United States in 1962. The company has 13 regional service centers that offer unlimited emergency service and support in the U.S.

For more information about JEOL USA, Inc. or any JEOL products, visit http://www.blogger.com/www.jeolusa.com, or call 978-535-5900.

Efficient Isolation of High Yield gDNA…

Agilent Automation Solutions has released an application note that demonstrates how the Agilent gDNA Isolation Workstation, utilizing the Invitrogen ChargeSwitch EasyPlex kit, provides the throughput, and walk-away time necessary to keep up with the demands of genomic applications.

Efficient isolation of high-yield gDNA is an important step in high-throughput analysis of the genome. Isolating gDNA can be accomplished by a number of approaches. Automated liquid-handling workstations can be used to isolate gDNA in a reliable, repeatable, and contamination-free manner. This application note outlines a protocol for the Invitrogen ChargeSwitch EasyPlex gDNA kit using the Agilent gDNA isolation workstation in which up to 10 microplates (96-well) can be processed simultaneously.  The throughput of the outlined protocol is 10 minutes for each plate processed (depending on exact liquid handling procedures).

In the described set-up - microplates and tip boxes were delivered to an Agilent Bravo Automated Liquid Handling Platform by an Agilent BenchCel Microplate Handling. The Bravo gripper was used to transport microplates and tip boxes around the platform. After the washing steps, the microplates were sealed with an Agilent PlateLoc Thermal Microplate Sealer and stored in the BenchCel Workstation for downstream use. The authors show how the Agilent Bravo Automated Liquid Handling Platform has the capacity for managing the necessary reagents, plates, and tips in a compact footprint. Further the integration of three Agilent BenchCel stackers for tip boxes is shown to provide an uninterrupted supply of tips without user intervention. The Agilent PlateLoc Thermal Microplate Sealer is shown to securely seal the plates after processing, and is easily integrated into the process workflow. Agilent VWorks Automation Control software was used to create an event-driven protocol to seamlessly integrate and reliably manage the entire process.

For a copy of the application note please visit www.chem.agilent.com/Library/applications/5990-3549en_lo%20CMS.pdf or contact your local Agilent Automation sales office.
.

Monday, 27 September 2010

High-Performance Mass Spectrometry Platforms and Advances in Applied Proteomics Solutions

At the Human Proteome Organisation's (HUPO) 9th Annual World Congress (www.hupo2010.com), Bruker displays leading technologies and solutions for proteomics in the next decade. Bruker's "Continuing Revolution" campaign demonstrates the company's commitment to enabling the proteomics community to pursue an ever increasing range of scientific investigations, as well as clinical proteomics research and emerging applied proteomics methods:
-- The autoflex(TM) speed is a flexible and high performance MALDI-TOF(/TOF) system specifically designed for enhanced workflows in proteomics research. The fields of MALDI tissue biomarker and drug imaging, where Bruker is leading and continually innovating, is greatly advanced by the novel FAST-SRM mode for single reaction monitoring capabilities. Enhanced speed and reliable operation are delivered by the 1 kHz smartbeam(TM)-II laser and the MALDI Perpetual(TM) self-cleaning ion source, previously introduced in Bruker's market leading ultrafleXtreme(TM) MALDI-TOF/TOF. Further enhancements on the autoflex speed as a proteomics platform for MALDI based workflows are its wide mass range resolving power of up to 26,000 delivered by the PAN(TM) technology, the innovative FlashDetector(TM) system and the novel 4 Gs/s digitizer. Edmass(TM) top-down intact protein sequencing for long sequence readouts, including Bruker's patented T³-Sequencing(TM) technology, is now fully supported on the autoflex speed.
-- High performance molecular imaging of small molecules including drugs, metabolites and lipids in tissue is now available on the new unrivalled MALDI-solariX(TM) FTMS platform, which combines extreme performance with resolving power > 1,000,000 at 7 tesla with a robust and highly sensitive MALDI source. Its unique instrument design with a dual ion funnel and quad-based ion selection for signal enhancement by CASI(TM) (continuous accumulation of selected ions) provides unparalleled sensitivity for the analysis of therapeutic doses of drugs and their metabolites directly in tissue. Its dual ESI/MALDI source allows easy switching between both ionization modes by simple push-button software. Fast data acquisition of up to 1 pixel/sec with the smartbeam(TM) II laser at a 1 kHz laser rate and laser spot sizes down to 20 um for high spatial resolution are essential features of this ultimate MALDI small molecule tissue imaging system.
-- As MALDI Imaging matures as a key proteomic application, it becomes essential to cover the complete workflow for effective and scientifically relevant clinical research. The MALDI Molecular Imager(TM) concept, on ultrafleXtreme and autoflex speed MALDI-TOF platforms, as well as on the solariX MALDI-FTMS, enables non-targeted molecular histology with high spatial resolution in an integrated solution (research use only) for biological tissue and clinical pathology investigations. The entire, highly effective workflow is provided by seamless integration of the mass spectrometers with sample preparation by the proprietary Bruker ImagePrep(TM) station and with the data processing software FlexImaging(TM). This workflow is completed by ClinProTools(TM), the first commercially available software solution for small molecule statistical class imaging. By continuous innovation, Bruker remains committed to the development of MALDI Imaging as a key proteomics technology.
-- Bruker provides high performance top-down protein sequencing and characterization workflows across a range of systems. A breakthrough has been recently achieved in collaboration with scientists by applying ETD on the maXis(TM) UHR-TOF system. High mass accuracy, resolving power and dynamic range, essential for the dissection of complex patterns of product ions in protein fragmentation, have been harnessed for the first time to perform ETD dissociation of intact biomolecules up to 150 kDa with ease. This represents a new record for mass spectrometric sequencing of intact proteins and demonstrates the dramatic advantages of maXis ETD technology in top-down protein structure analysis. This achievement underlines Bruker's leading position in all fields of top-down proteomics.
-- The amaZon ETD, Bruker's 4th generation ion trap platform, offers class leading ETD and PTR (Proton Transfer Reaction) for unmatched sensitivity in an extremely robust setup. Ion trap mass resolving power up to 20,000 in full scan mode across the 50-3000 m/z range with scan speeds up to 52,000 u/sec, fast enough to be useable for LC coupling, make real-life, routine LC-ETD experiments for PTMs a reality.
-- MALDI-ISD (In-Source Decay), leveraging innovations incorporated into the industry leading ultrafleXtreme and autoflex speed MALDI-TOF(-TOF) platforms completes Bruker's comprehensive set of workflows as the leading supplier for top-down protein sequencing and characterization.
-- Bruker's ProteinScape(TM) 2.1 software is the most established proteomics bioinformatics platform addressing scientists' needs in biomarker profiling, quantification and validation. As a comprehensive solution for qualitative and quantitative LC-MS/MS protein analysis, ProteinScape supports all current label chemistries including multiplexed labels, as well as label-free quantification. Interactive validation of protein quantification based on raw LC/MS data is simple and straight forward. It streamlines the discovery process through decoy auto-validation algorithms, combined database searches with various algorithms and the ProteinExtractor(TM) module that produces non-redundant protein result lists across entire proteomics projects. Its archiving capabilities allow the retrieval of data generated years ago, e.g. for their joint re-analysis with novel analytic capabilities and mining tools. The ProteinScape processing pipeline adopts the "HUPO Brain Proteomics Project processing guidelines" (forum.hbpp.org) and will facilitate the direct submission process of project data adhering to HUPO/PSI publishing guidelines.
Clive Seymour, Executive Vice President of Bruker Daltonics, commented: "As the field of proteomics evolves, Bruker continues to innovate and deliver workflows suited to the needs of those engaged in an expanding discipline. Offering solutions based on a broad range of technologies and workflows without compromising performance and ease of use, underlines the philosophy and defines our leadership in proteomics. Whatever the application, whether it is 'traditional' expression proteomics or novel fields such as top-down proteomics, tissue imaging or quantitation with or without labels, we strive to provide the highest performance solutions."
In addition to supporting HUPO 2010 as a Gold Sponsor, Bruker will be present in the scientific program with more than 40 contributions. Bruker Daltonics staff will be available for in-depth meetings during exhibit hours at Bruker's booth (No. 1). The Bruker Luncheon Seminars will be held on Tuesday, September 21st, 12:30-1:30 PM, in the Baysite Gallery Auditorium A during which a panel of prestigious international researchers including Christoph Borchers from ProteomeCenter, Victoria, Canada, and Keith Ashman, CNIO Madrid, Spain, will present talks, detailing a series of innovative proteomic applications. For more information on Bruker's HUPO events, please visit www.bdal.com/hupo

JUST PUBLISHED: The latest issue of Sensors & Actuators A: Physical